Success Story: NIW Approval for a Nephrology Expert in Only 1 Month under Premium Processing

Posted by wegreened on June 8, 2026 in NIW, Nephrology

Client’s Testimonial:

"I am very grateful for the support and expertise provided throughout my EB-2 NIW petition process. From the very beginning, the team demonstrated a deep understanding of both the legal framework and the scientific nuances of my work in nephrology. They carefully crafted my case by paying attention to details. Preparing the case was sometimes challenging because they wanted to make it perfect to avoid RFEs. Their guidance in organizing my publications, citations, and recommendation letters made a significant difference in strengthening my application.

Thanks to their efficiency and professionalism, my petition was approved in just over one month under premium processing, which exceeded my expectations. I felt supported at every step of the process. Their dedication, experience, and strategic approach truly set them apart."

On April 3^rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Physician in the Field of Nephrology (Approval Notice).

General Field: Nephrology

Position at the Time of Case Filing: Physician

Country of Origin: Turkey

State of Residence at the Time of Filing: Texas

Approval Notice Date: April 3^rd, 2026

Processing Time: 1 month, 1 day (Premium Processing Requested)

Case Summary:

Our firm is pleased to share the approval of an EB-2 NIW (National Interest Waiver) petition for a physician in the field of nephrology, specializing in the molecular mechanisms of chronic kidney disease and targeted therapeutic development. With over 32,000 successful cases to our name, we are proud that our expert team's thorough preparation secured a well-deserved approval in just over one month under premium processing.

Client Background and Proposed Endeavor

Holding an M.D., this researcher brings specialized clinical and scientific expertise in glomerulopathies, genetic kidney disorders, and precision medicine. The proposed endeavor is to continue developing targeted therapeutic approaches for identifying personalized risk factors at the molecular level and genetic mutations in a range of glomerulopathies and genetic kidney disorders, to prevent or slow the progression of chronic kidney disease.

National Significance of Research

We emphasized that this research carries significant importance and has far-reaching implications for the United States. Chronic kidney disease affects tens of millions of Americans, the vast majority of whom remain undiagnosed, placing an enormous burden on the national healthcare system. By advancing early detection, molecular diagnostics, and personalized treatment strategies, this researcher's work directly addresses this critical public health challenge. The proposed endeavor aligns with key federal research priorities focused on accelerating health and biotechnology breakthroughs and has been recognized as advancing a critical and emerging technology area of strategic national importance.

Impressive Credentials and Achievements

To further strengthen the case, we highlighted exceptional credentials:

Publications: An impressive portfolio of 8 peer-reviewed journal articles (2 of them first-authored) and 8 published abstracts (2 of them first-authored).

Citations: The published body of work has been cited 114 times.

Peer Review Service: At least 1 peer review has been completed for a respected international publishing platform in the field, reflecting recognition as an expert evaluator by the broader academic community.

Recommendation Letters

The petition was supported by three recommendation letters from leading experts in nephrology. One expert remarked:

"Undoubtedly, [Client] continues to produce additional valuable work, both progressing nephrology research and bringing immense benefits to the United States research community’s global leadership."

Case Outcome

This client's pioneering contributions to the understanding of genetic kidney disease mechanisms, molecular pathways, and precision medicine approaches position the client to make meaningful and lasting contributions to U.S. healthcare and nephrology leadership for years to come. We are honored to have supported this journey and extend our sincere best wishes for continued success in both clinical and research pursuits.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%